Fresenius Medical Care AG & Co. KGaA ADR (FMS) Social Stream
FRESENIUS MEDICAL CARE AG (FMS) Price Targets From Analysts
Use the tables below to see what analysts covering FRESENIUS MEDICAL CARE AG think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 4 | $46 | $35.4 | $40.466 | $20.86 | 93.99% |
| 2021-11-11 | 4 | $46 | $32.4 | $39.466 | $20.86 | 89.19% |
| 2021-11-17 | 5 | $46 | $32.4 | $38.35 | $20.86 | 83.84% |
| 2022-01-25 | 5 | $46 | $32.4 | $37.1 | $20.86 | 77.85% |
| 2022-02-22 | 5 | $46 | $30.3 | $36.575 | $20.86 | 75.34% |
| 2022-02-23 | 5 | $46 | $30.3 | $37.075 | $20.86 | 77.73% |
| 2022-05-04 | 5 | $35 | $30.3 | $33.575 | $20.86 | 60.95% |
| 2022-06-22 | 5 | $35 | $27 | $31.825 | $20.86 | 52.56% |
| 2022-07-21 | 5 | $35 | $25 | $30.175 | $20.86 | 44.65% |
| 2022-08-02 | 6 | $35 | $25 | $30.175 | $20.86 | 44.65% |
| 2022-09-17 | 6 | $35 | $20 | $28.425 | $20.86 | 36.27% |
| 2022-10-10 | 6 | $35 | $14 | $23.5 | $20.86 | 12.66% |
| 2022-10-12 | 6 | $35 | $14 | $22.25 | $20.86 | 6.66% |
| 2022-11-04 | 7 | $35 | $14 | $22.25 | $20.86 | 6.66% |
| 2023-01-03 | 5 | $15 | $11.7 | $13.35 | $20.86 | -36% |
| 2023-01-05 | 5 | $17 | $11.7 | $14.35 | $20.86 | -31.21% |
| 2023-02-23 | 5 | $22 | $11.7 | $16.85 | $20.86 | -19.22% |
| 2023-03-14 | 5 | $22 | $11.2 | $16.6 | $20.86 | -20.42% |
| 2023-04-13 | 5 | $24 | $11.2 | $17.6 | $20.86 | -15.63% |
| 2023-05-10 | 5 | $26 | $11.2 | $18.6 | $20.86 | -10.83% |
| 2023-06-02 | 7 | $26 | $11.3 | $18.65 | $20.86 | -10.59% |
| 2023-07-13 | 6 | $28 | $11.3 | $19.65 | $20.86 | -5.8% |
| 2023-08-02 | 7 | $28 | $11.3 | $19.65 | $20.86 | -5.8% |
| 2023-08-06 | 8 | $28 | $15.9 | $21.95 | $20.86 | 5.23% |
| 2023-11-02 | 8 | $24 | $15.9 | $19.95 | $20.86 | -4.36% |
| 2023-11-15 | 9 | $24 | $15.9 | $19.95 | $20.86 | -4.36% |
The Trend in the Analyst Price Target
FMS's average price target has moved up $1.95 over the prior 13 months.
FMS reports an average of -10.91% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-05 | 5 | 17 | 11.7 | 14.35 | 16.92 | -15.19% |
| 2023-02-23 | 5 | 22 | 11.7 | 16.85 | 19.87 | -15.2% |
| 2023-04-13 | 5 | 24 | 11.2 | 17.60 | 22.61 | -22.16% |
| 2023-07-13 | 6 | 28 | 11.3 | 19.65 | 26.26 | -25.17% |
| 2023-10-11 | 8 | 24 | 15.9 | 19.95 | 17.27 | 15.52% |
FMS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.67 | 3 | 0 | 4 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
FMS's average broker recommendation rating worsened by 0.82 over the prior 38 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, FRESENIUS MEDICAL CARE AG's upside potential (average analyst target price relative to current price) is greater than 1108.02% of them.
- In terms of how FRESENIUS MEDICAL CARE AG fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is greater than 196.98% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, FRESENIUS MEDICAL CARE AG's average analyst price target is higher than 407.12% of them.
- FRESENIUS MEDICAL CARE AG's variance in analysts' estimates is lower than -1566.77% of stocks in the large market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to FRESENIUS MEDICAL CARE AG are DVA, DGX, and LH.
View All Top Stocks by Price Target
What is the outlook for FMS? Use POWR Ratings for clearer insight into price direction.